Position in BNTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$50,209,126
+$16,023,570 QoQ
Shares Held
539,593
+40.3% QoQ
Ownership
0.215%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#19
of 282 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 77%
Shared 3%
None 20%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $9,179,114,031 across 176 Biotechnology names. BNTX ranks #36 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,771,839 | $1,728,352,485 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,347,253 | $1,662,680,977 | |
| 3 | ASND |
Ascendis Pharma A/S
|
1,862,503 | $496,766,798 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
2,040,250 | $491,639,040 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,488,394 | $278,746,426 | |
| 6 | INSM |
INSMED Inc
|
2,273,222 | $242,370,927 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
752,044 | $237,713,585 | |
| 8 | ARGX |
Argenx SE
|
224,930 | $208,683,303 |
All Filings in BNTX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $50,209,126 | 539,593 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $34,185,556 | 384,626 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $55,016,079 | 577,900 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $72,270,312 | 732,816 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $80,065,225 | 751,998 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $38,740,747 | 425,442 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $15,586,763 | 136,786 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $401,917 | 3,384 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $673,415 | 8,380 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $871,854 | 9,451 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,044,000 | 9,892 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $403,597 | 3,715 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $425,567 | 3,943 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $489,185 | 3,927 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $414,456 | 2,759 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $281,494 | 2,087 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $311,171 | 2,087 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $393,993 | 2,310 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $82,371,482 | 319,517 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $110,477,687 | 404,695 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $57,232,011 | 255,637 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $333,793 | 3,057 | Shares | Defined | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||